These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1409376)
1. Brain parenchymal metabolism of 5-iodo-2'-deoxyuridine and 5'-ester prodrugs. Ghosh MK; Mitra AK Pharm Res; 1992 Aug; 9(8):1048-52. PubMed ID: 1409376 [TBL] [Abstract][Full Text] [Related]
2. Enhanced delivery of 5-iodo-2'-deoxyuridine to the brain parenchyma. Ghosh MK; Mitra AK Pharm Res; 1992 Sep; 9(9):1173-6. PubMed ID: 1409400 [TBL] [Abstract][Full Text] [Related]
3. Effects of 5'-ester modification on the physicochemical properties and plasma protein binding of 5-iodo-2'-deoxyuridine. Ghosh MK; Mitra AK Pharm Res; 1991 Jun; 8(6):771-5. PubMed ID: 2062808 [TBL] [Abstract][Full Text] [Related]
4. Prodrugs of 5-iodo-2'-deoxyuridine for enhanced ocular transport. Narurkar MM; Mitra AK Pharm Res; 1989 Oct; 6(10):887-91. PubMed ID: 2608631 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, physicochemical properties, and cytotoxicity of a series of 5'-ester prodrugs of 5-iodo-2'-deoxyuridine. Narurkar MM; Mitra AK Pharm Res; 1988 Nov; 5(11):734-7. PubMed ID: 3247280 [TBL] [Abstract][Full Text] [Related]
6. New oligoethylene ester derivatives of 5-iodo-2'-deoxyuridine as dermal prodrugs: synthesis, physicochemical properties, and skin permeation studies. Bonina FP; Rimoli MG; Avallone L; Barbato F; Amato M; Puglia C; Ricci M; De Caprariis P J Pharm Sci; 2002 Jan; 91(1):171-9. PubMed ID: 11782906 [TBL] [Abstract][Full Text] [Related]
8. Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of ketoprofen. Huttunen KM Bioorg Chem; 2018 Dec; 81():494-503. PubMed ID: 30243240 [TBL] [Abstract][Full Text] [Related]
9. Effects of the ester moiety on stereoselective hydrolysis of several propranolol prodrugs in rat tissues. Takahashi K; Tamagawa S; Sakano H; Katagi T; Mizuno N Biol Pharm Bull; 1995 Oct; 18(10):1401-4. PubMed ID: 8593445 [TBL] [Abstract][Full Text] [Related]
10. Identification of carboxylesterases expressed in rat intestine and effects of their hydrolyzing activity in predicting first-pass metabolism of ester prodrugs. Liu D; Gao J; Zhang C; Ren X; Liu Y; Xu Y Pharmazie; 2011 Nov; 66(11):888-93. PubMed ID: 22204136 [TBL] [Abstract][Full Text] [Related]
11. Prodrugs for systemic bioreductive activation-independent delivery of phyllohydroquinone, an active form of phylloquinone (vitamin K1). 1: Preparation and in vitro evaluation. Takata J; Karube Y; Matsunaga K; Hanada M; Hidaka R; Matsushima Y Biol Pharm Bull; 1999 Dec; 22(12):1347-54. PubMed ID: 10746168 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of alpha-phosphonosulfonate squalene synthase inhibitors. I. Disposition of a farnesylethyl alpha-phosphonosulfonate and ester prodrugs in rats. Lan SJ; Hsieh DC; Hillyer JW; Fancher RM; Rinehart KJ; Warrack BM; White RE Drug Metab Dispos; 1998 Oct; 26(10):993-1000. PubMed ID: 9763405 [TBL] [Abstract][Full Text] [Related]
13. Chemical synthesis of an indomethacin ester prodrug and its metabolic activation by human carboxylesterase 1. Takahashi M; Ogawa T; Kashiwagi H; Fukushima F; Yoshitsugu M; Haba M; Hosokawa M Bioorg Med Chem Lett; 2018 Apr; 28(6):997-1000. PubMed ID: 29503023 [TBL] [Abstract][Full Text] [Related]
14. Absorption of ester prodrugs in Caco-2 and rat intestine models. He X; Sugawara M; Takekuma Y; Miyazaki K Antimicrob Agents Chemother; 2004 Jul; 48(7):2604-9. PubMed ID: 15215116 [TBL] [Abstract][Full Text] [Related]
15. Adamantane as a brain-directed drug carrier for poorly absorbed drug. 2. AZT derivatives conjugated with the 1-adamantane moiety. Tsuzuki N; Hama T; Kawada M; Hasui A; Konishi R; Shiwa S; Ochi Y; Futaki S; Kitagawa K J Pharm Sci; 1994 Apr; 83(4):481-4. PubMed ID: 8046599 [TBL] [Abstract][Full Text] [Related]
16. Stereoselective hydrolysis of xenobiotic esters by different cell lines from rat liver and hepatoma and its application to chiral prodrugs for designated growth suppression of cancer cells. Kageyama Y; Yamazaki Y; Afify AS; Ogawa Y; Okada T; Okuno H Chirality; 1995; 7(4):297-304. PubMed ID: 7640174 [TBL] [Abstract][Full Text] [Related]
17. Structure-metabolism relationships in the hydrolysis of nicotinate esters by rat liver and brain subcellular fractions. Durrer A; Walther B; Racciatti A; Boss G; Testa B Pharm Res; 1991 Jul; 8(7):832-9. PubMed ID: 1924134 [TBL] [Abstract][Full Text] [Related]
18. Species differences in stereoselective hydrolase activity in intestinal mucosa. Yoshigae Y; Imai T; Horita A; Matsukane H; Otagiri M Pharm Res; 1998 Apr; 15(4):626-31. PubMed ID: 9587961 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate. Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model. Chen W; Yang JZ; Andersen R; Nielsen LH; Borchardt RT J Pharmacol Exp Ther; 2002 Nov; 303(2):849-57. PubMed ID: 12388672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]